Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Follow-on Biologics in the News

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn --Innovators Looking for Help from Follow-on Biologics Last week, Merck announced that it had acquired Insmed's portfolio of follow-on biologic therapeutic candidates as well as its biologics manufacturing facilities in Boulder, CO (see "Biotech/Pharma Business Briefs"). While the timing and target of the acquisition may have been somewhat surprising, Merck's move into follow-on biologics was not, as the company revealed plans to do so back in December (see Reuters report). With respect to the acquisition's timing, Merck's purchase of Insmed's follow-on biologics technology comes less than ten weeks after Merck announced the creation of Merck BioVentures, a...

Full post as published by Patent Docs on February 19, 2009 (boomark / email).